OBIO launches first Early Adopter Health Network in Ontario
The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization in Ontario, announce today’s launch of the province’s first-of-its-kind Early Adopter Health Network (EAHN). The EAHN is a network of health organizations that get leading-edge technologies into the health system.
Reviewing the 2020 Niagara Investment Summit – A Very Canadian Ending
Reviewing the 2020 Niagara Investment Summit – Day 2: A Fireside Chat with David Skok
H2BB Training Days Have Begun
Last week OBIO hosted our newest H2BB trainees for the introductory sessions of our Innovation & Commercialization and Project Management training modules.
Reviewing the 2020 Niagara Investment Summit – Day 2: Jeff Karp Keynote Address
Reviewing the 2020 Niagara Investment Summit – What were you saying?
Reviewing the 2020 Niagara Investment Summit – Day 2: Dr. Dave Williams Keynote Address
2020 Niagara Investment Summit a Success
The 2020 Niagara Investment Summit brought together a record number of health science industry leaders, entrepreneurs and global investors to meet, learn and be inspired. Summaries and photo galleries are now available.
Future of Health Care in Canada: OBIO Investment Summit Connects Global Investors, Leading-Edge Health Companies
Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.
OBIO 2019 Annual Public Meeting: Recap and Photo Gallery
The OBIO Annual Public Meeting took place on November 25 and included a celebration of 10 years of the organization’s contributions to Ontario’s health science sector and a look to the future with a presentation highlighting the emerging field of digital therapeutics.
OBIO in Kitchener-Waterloo Health Science Networking Event
OBIO visited Kitchener-Waterloo on November 13 to meet and network with health science companies and industry stakeholders. The day was capped off with OBIO’s Health Science Network Event, supported by Bereskin & Parr and Communitech.
OBIO Hosts: Amplify Capital
On November 4th, OBIO hosted Amplify Capital (formerly MaRS Catalyst Fund) and heard from Kathryn Worstman (Managing Partner, Amplify Capital) and Gonen Hollander (Senior Associate, Amplify Capital) present their impact investment strategy.
OBIO’s “Project Management Essentials for Every Health Science Entrepreneur” Event in Review
On October 24th, OBIO hosted “Project Management Essentials for Every Health Science Entrepreneur” led by Ashwini Bhaskar who shared from his 20 years of experience. The purpose of the workshop was to introduce basic project knowledge and common terminology, to provide insights into where to go for more information and provide some simple take-aways that could be used immediately.
Reviewing OBIO's Primary Market Research Workshop
Last week OBIO hosted Gary Svoboda (CEO, Adventus Research + Consulting) who provided the audience practical steps they can use to validate technology with primary market research.
OBIO at MedTech Conference in Boston
This year's AdvaMed MedTech Conference in Boston was a fantastic event. OBIO was in attendance for meetings and conversations with US and global investors and strategics about what's coming up for the health science industry in Canada. There was tons of enthusiasm and interest to capitalize on as we head into 2020.
Recap: OBIO CAAP Alumni Group Dinner
On September 17th, OBIO held a dinner to bring together CAAP and CAAP Alumni companies. OBIO would like to thank everyone who came out and joined us to discuss common experiences, challenges and what's coming next.
Reviewing OBIO at RESI Boston
On September 10th, OBIO organized a cross-border networking event in Boston at the Consulate General of Canada. The event was supported by the Consulate General and law firms Fasken and Choate. Over 45 investors, strategics, as well as executives from high potential Canadian health science companies packed the Canada Room at the Consulate and resulted in numerous investor-company interactions.
FedDev Ontario announces $6.24 million investment in OBIO
FedDev Ontario is investing up to $6.24 million for the Ontario Bioscience Innovation Organization (OBIO®) to boost investment, market access and mentorship opportunities for companies across southern Ontario looking to commercialize their medical innovations.
Reviewing 'In-Licensing from Tech Transfer Offices: Terms, Tips & Impact on Investability'
On August 21st, OBIO hosted Norton Rose Fulbright’s Anthony de Fazekas (Partner, Head of Technology & Innovation) and Vanessa Grant (Partner), Lumira Ventures’ Jacki Jenuth (Partner), and University of Toronto’s Karen Temple (Commercialization Manager) who discussed practical considerations for licensing health science technologies from tech transfer offices, and how these agreements can impact a company’s future investability.
OBIO Hosts Happy Hour Networking Event
On July 25th, OBIO hosted a Happy Hour Networking event attended by over 40 CEOs and senior health science company executives. Attendees networked with fellow entrepreneurs and heard about OBIO’s upcoming plans for the fall.